ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,612,048 | +4.9% | 1,213,285 | -0.0% | 0.06% | +13.7% |
| Q2 2023 | $108,289,262 | -25.0% | 1,213,325 | -9.9% | 0.05% | -29.2% |
| Q1 2023 | $144,307,794 | -14.2% | 1,345,904 | -2.3% | 0.07% | -17.2% |
| Q4 2022 | $168,236,762 | +41.2% | 1,377,522 | +19.4% | 0.09% | +33.8% |
| Q3 2022 | $119,171,000 | +33.8% | 1,154,092 | +20.5% | 0.06% | +47.7% |
| Q2 2022 | $89,059,000 | -17.7% | 958,037 | +3.9% | 0.04% | +2.3% |
| Q1 2022 | $108,168,000 | -12.5% | 921,681 | +0.2% | 0.04% | -4.4% |
| Q4 2021 | $123,689,000 | -6.5% | 919,413 | +10.8% | 0.04% | -10.0% |
| Q3 2021 | $132,247,000 | +26.6% | 829,711 | +4.5% | 0.05% | +25.0% |
| Q2 2021 | $104,486,000 | +10.7% | 794,263 | +8.5% | 0.04% | +5.3% |
| Q1 2021 | $94,388,000 | -22.7% | 732,375 | +0.0% | 0.04% | -26.9% |
| Q4 2020 | $122,094,000 | +10.6% | 732,063 | +2.3% | 0.05% | -1.9% |
| Q3 2020 | $110,405,000 | +11.0% | 715,433 | +2.5% | 0.05% | +3.9% |
| Q2 2020 | $99,499,000 | +26.2% | 698,043 | -0.3% | 0.05% | -3.8% |
| Q1 2020 | $78,845,000 | -30.8% | 700,160 | -14.5% | 0.05% | -11.7% |
| Q4 2019 | $113,904,000 | +34.7% | 818,742 | -6.8% | 0.06% | +30.4% |
| Q3 2019 | $84,592,000 | -16.3% | 878,234 | +0.0% | 0.05% | -14.8% |
| Q2 2019 | $101,091,000 | -2.2% | 877,904 | -0.0% | 0.05% | -1.8% |
| Q1 2019 | $103,363,000 | +165.8% | 878,187 | +41.5% | 0.06% | +139.1% |
| Q4 2018 | $38,881,000 | -7.3% | 620,598 | +4.8% | 0.02% | +9.5% |
| Q3 2018 | $41,942,000 | +14.8% | 591,898 | +7.8% | 0.02% | +10.5% |
| Q2 2018 | $36,526,000 | +11.4% | 549,098 | +9.6% | 0.02% | +11.8% |
| Q1 2018 | $32,777,000 | – | 501,167 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |